| Financial Year |
March 31 2023 |
| Monetary Funds |
853,201,950.23 |
| Held-for-trading Financial Assets |
261,796,859.00 |
| Notes Receivable |
2,158,000.00 |
| Accounts Receivable |
568,072,935.58 |
| Advances to Suppliers |
108,687,519.31 |
| Other Receivables |
252,916,444.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
55,162,079.83 |
| Dividend Receivable |
-- |
| Inventories |
295,307,415.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,014,185.66 |
| Other Current Assets |
135,978,822.33 |
| Total Current Assets |
2,569,307,075.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
299,328,072.77 |
| Long-term Equity Investment |
553,586,455.09 |
| Investment Properties |
-- |
| Fixed Assetes |
2,317,085,348.21 |
| Under-construction Projects |
677,783,808.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
375,669,619.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,209,764.04 |
| Deferred Income Tax Assets |
116,018,203.77 |
| Other Non-Current Assets |
582,784,911.47 |
| Sub-Total of Non-Current Assets |
5,229,166,183.19 |
| Total Assets |
7,798,473,258.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,256,230.33 |
| Accounts Payable |
196,212,196.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,652,976.74 |
| Taxes Payable |
29,909,591.57 |
| Interest Payable |
-- |
| Dividend Payable |
3,661,463.13 |
| Other payables |
10,054,866.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
104,500,000.00 |
| Other Current Liabilities |
36,533,754.11 |
| Sub-Total of Current Liabilities |
1,725,790,934.64 |
| Long-term Loans |
245,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
101,395,840.63 |
| Deferred Income Tax Liabilities |
39,768,302.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
420,253,833.39 |
| Total Liabilities |
2,146,044,768.03 |
| Paid-In Capital(Or Share Stock) |
836,749,606.00 |
| Capital Surplus |
3,367,251,815.23 |
| Surplus Reserve |
108,512,446.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,034,869,288.29 |
| Minority Stockholder's Interest |
302,977,016.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,349,451,474.19 |
| Owner's Equity（Stockholder's Equity） |
5,652,428,490.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,798,473,258.42 |
